Trial Profile
Comparison of intravenous and subcutaneous bortezomib in patients with Multiple Myeloma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 May 2015
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Bendamustine; Bortezomib; Cyclophosphamide; Dexamethasone; Doxorubicin; Melphalan; Prednisone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 20 May 2015 New trial record